Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Capital Expenditures
The capex for Labcorp Holdings Inc. (LH) is $434.50 Million with a year-over-year change of -11.31%. Capital Expenditures (CapEx) represents spending on physical assets like property, plant, equipment, and technology infrastructure. It's the investment in the company's future productive capacity.
LH CapEx Chart
LH CapEx
$434.50M+364.21% 20Y
Zoom
Current CapEx
$434.50M
$434.50 Million
Year-over-Year Change
-11.31%
vs. $489.90M prior year
Historical Data
30
Years of data available
Annual CapEx History
| Year | CapEx | YoY Change | % Change |
|---|---|---|---|
| 2025 | $434.50M | $-55.40M | -11.31% |
| 2024 | $489.90M | +$36.30M | +8.00% |
| 2023 | $453.60M | $-28.30M | -5.87% |
| 2022 | $481.90M | +$21.50M | +4.67% |
| 2021 | $460.40M | +$78.70M | +20.62% |
| 2020 | $381.70M | $-18.50M | -4.62% |
| 2019 | $400.20M | +$20.40M | +5.37% |
| 2018 | $379.80M | +$64.40M | +20.42% |
| 2017 | $315.40M | +$36.50M | +13.09% |
| 2016 | $278.90M | +$23.10M | +9.03% |
| 2015 | $255.80M | +$52.30M | +25.70% |
| 2014 | $203.50M | +$1.30M | +0.64% |
| 2013 | $202.20M | +$25.90M | +14.69% |
| 2012 | $176.30M | +$30.60M | +21.00% |
| 2011 | $145.70M | +$19.20M | +15.18% |
| 2010 | $126.50M | +$11.80M | +10.29% |
| 2009 | $114.70M | $-42.00M | -26.80% |
| 2008 | $156.70M | +$13.40M | +9.35% |
| 2007 | $143.30M | +$26.80M | +23.00% |
| 2006 | $116.50M | +$22.90M | +24.47% |
| 2005 | $93.60M | $-1.40M | -1.47% |
| 2004 | $95.00M | +$11.40M | +13.64% |
| 2003 | $83.60M | +$9.30M | +12.52% |
| 2002 | $74.30M | $-13.80M | -15.66% |
| 2001 | $88.10M | +$32.60M | +58.74% |
| 2000 | $55.50M | $-13.90M | -20.03% |
| 1999 | $69.40M | $-13.00M | -15.78% |
| 1998 | $82.40M | +$47.90M | +138.84% |
| 1997 | $34.50M | $-19.60M | -36.23% |
| 1996 | $54.10M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter